BIM

115.6

+1.67%↑

SRT3

228.7

-0.91%↓

ICAD

21.04

-0.47%↓

BIM

115.6

+1.67%↑

SRT3

228.7

-0.91%↓

ICAD

21.04

-0.47%↓

BIM

115.6

+1.67%↑

SRT3

228.7

-0.91%↓

ICAD

21.04

-0.47%↓

BIM

115.6

+1.67%↑

SRT3

228.7

-0.91%↓

ICAD

21.04

-0.47%↓

BIM

115.6

+1.67%↑

SRT3

228.7

-0.91%↓

ICAD

21.04

-0.47%↓

Search

Gerresheimer AG

Fermé

SecteurSoins de santé

55.35 3.07

Résumé

Variation du prix de l'action

24h

Actuel

Min

52.85

Max

55.65

Chiffres clés

By Trading Economics

Revenu

-56M

-17M

Ventes

-49M

520M

P/E

Moyenne du Secteur

22.741

57.333

BPA

0.46

Rendement du dividende

2.41

Marge bénéficiaire

-3.363

Employés

13,632

EBITDA

-33M

84M

Recommandations

By TipRanks

Recommandations

Achat Fort

Prévisions sur 12 Mois

+83.02% upside

Dividendes

By Dow Jones

Rendement du dividende

Moyenne du Secteur

2.41%

2.63%

Prochains Résultats

10 juil. 2025

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-40M

1.8B

Ouverture précédente

52.28

Clôture précédente

55.35

Score Technique

By Trading Central

Confiance

Bullish Evidence

Gerresheimer AG Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

4 avr. 2025, 10:15 UTC

Principaux Mouvements du Marché
Acquisitions, Fusions, Rachats

Gerresheimer Shares Fall After Report That KKR Exited Consortium Seeking Bid

4 avr. 2025, 09:39 UTC

Acquisitions, Fusions, Rachats

KKR Drops Out of Consortium Attempting Gerresheimer Takeover, Bloomberg Says, Citing Sources

13 mai 2024, 11:16 UTC

Actualités

German Companies Bet on AI But Payoff Could Be Years Away -- Talking Markets

Comparaison

Variation de prix

Gerresheimer AG prévision

Objectif de Prix

By TipRanks

83.02% hausse

Prévisions sur 12 Mois

Moyen 98.1 EUR  83.02%

Haut 122.5 EUR

Bas 84.5 EUR

Basé sur 12 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat Fort

12 ratings

11

Achat

1

Maintien

0

Vente

Score Technique

By Trading Central

53.05 / 53.85Support & Résistance

Court Terme

Bullish Evidence

Moyen Terme

Strong Bearish Evidence

Long Terme

Neutral Evidence

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Gerresheimer AG

Gerresheimer AG, together with its subsidiaries, manufactures and sells medicine packaging, drug delivery devices, and solutions in Germany and internationally. It operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The company offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, and glass bottles and jars, as well as caps, closures, applicators, and accessories; development, industrialization and contract manufacturing of drug delivery programs; project and quality management; and drug delivery systems, including inhalers, injection/auto injectors, pen injectors, infusion systems, and inhalation assessment, autoinjector, and other services. It also provides diagnostic and medical devices comprising point-of-care tests, laboratory disposables, chemical and technical bottles, diagnostic and polymer vials, dropper bottles, PET bottles, and medical products comprising lancing devices, infusion sets, and disposable systems. In addition, the company offers cosmetic packaging solutions, such as moulded glass flacons and jars; tubular glass ampoules, droppers, samplers and vials; and plastic packaging products, as well as pharmaceutical, laboratory, and regulatory affairs services. It offers its products to pharmacy chains, supermarkets, and wholesalers. The company serves pharma, biotech, medical technology, diagnostics, cosmetics, glass containers, and food and beverage industries. Gerresheimer AG was founded in 1864 and is based in Düsseldorf, Germany.